Angiogenesis: Principles and Importance in Cancer and Ischemic Heart Disease
Chairs: Jeffrey L. Evelhoch, Roderic I. Pettigrew and Robert M . Weisskoff
Upon completion of this session participants should be able to:
Explain the basic principles of angiogenesis and its importance in cancer and ischemic heart disease.
Describe the principles of anti-angiogenic therapy and its potential clinical utility in oncology.
Explain the basis underlying MR methods used to assess the extent of angiogenesis in vivo.
List examples of information which MR studies of tumors in vivo can provide regarding the angiogenic process.
Describe the principles of angiogenic gene therapy and its potential clinical utility in ischemic heart disease.
|08:15 139. Angiogenesis: Fundamental and Medical Applications, Judah Folkman, Harvard University Medical School, Boston, MA, USA.|
|08:40 140. MR Evaluation of Angiogenesis in Oncology, Michal Neeman, Weizmann Institute of Science, Rehovot, Israel.|
|09:05 141. Angiogenic Therapy in Ischemic Heart Disease, Stephen E. Epstein, Cardiovascular Research Foundation at Washington Hospital Center, Washington, D.C., USA.|
Return to ISMRM program